This is a working overview of mass spectrometry, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-19 and is reviewed periodically as new material appears.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
=== Antivenene research and production === In 1928, CSL also became involved in antivenene (antivenom) manufacture in conjunction with the snake venom research undertaken by Charles Kellaway at the Hall Institute. This led to the successful clinical testing of antivenene against tiger snake Notechis scutatus bite in 1930 and its commercial release in 1931. In 1934, the research on snake venoms was transferred from the Hall Institute to CSL under the direction of former snake showman and herpetologist Tom "Pambo" Eades. This represented the initiation of research at the laboratories – an outcome its directors had been seeking for over a decade. The relationship with the Hall Institute continued until World War II, particularly via joint projects on viral diseases including polio and influenza coordinated by Frank Macfarlane Burnet and Esmond "Bill" Keogh. Keogh played an important role in the establishment of penicillin production at CSL in 1944 – a critical wartime achievement.
== Non-traditional use == In the late 20th century, the practice of ayahuasca drinking began spreading to Europe, North America and elsewhere. The first ayahuasca churches, affiliated with the Brazilian Santo Daime, were established in the Netherlands. A legal case was filed against two of the Church's leaders, Hans Bogers (one of the original founders of the Dutch Santo Daime community) and Geraldine Fijneman (the head of the Amsterdam Santo Daime community). Bogers and Fijneman were charged with distributing a controlled substance (DMT); however, the prosecution was unable to prove that the use of ayahuasca by members of the Santo Daime constituted a sufficient threat to public health and order such that it warranted denying their rights to religious freedom under ECHR Article 9. The 2001 verdict of the Amsterdam district court is an important precedent. Since then groups that are not affiliated to the Santo Daime have used ayahuasca, and a number of different "styles" have been developed, including non-religious approaches. In Peru, retreat centers such as Blue Morpho, founded by Hamilton Souther, in Iquitos began offering ayahuasca ceremonies to foreign visitors around 2004. International media coverage brought wider attention to the practice and coincided with the growth of ayahuasca tourism.
==== Fear and anxiety ==== Oxytocin is typically remembered for its effects on prosocial behaviors, such as its role in facilitating trust and attachment between individuals. However, oxytocin has a more complex role than solely enhancing prosocial behaviors. There is consensus that oxytocin modulates fear and anxiety; that is, it does not directly elicit fear or anxiety. Two dominant theories explain the role of oxytocin in fear and anxiety. One theory states that oxytocin increases approach/avoidance to certain social stimuli, and the second theory states that oxytocin increases the salience of certain social stimuli, causing animals (including humans) to pay closer attention to socially relevant stimuli. Nasally administered oxytocin has been reported to reduce fear, possibly by inhibiting the amygdala (which is thought to be responsible for fear responses). Indeed, studies in rodents have shown oxytocin can efficiently inhibit fear responses by activating an inhibitory circuit within the amygdala. Some researchers have argued oxytocin has a general enhancing effect on all social emotions, since intranasal administration of oxytocin also increases envy and Schadenfreude. Individuals who receive an intranasal dose of oxytocin identify facial expressions of disgust more quickly than individuals who do not receive oxytocin. Facial expressions of disgust are evolutionarily linked to the idea of contagion. Thus, oxytocin increases the salience of cues that imply contamination, which leads to a faster response because these cues are especially relevant for survival.
For centuries, hair removal has long shaped gender roles, served to signify social status and defined notions of femininity and the ideal "body image". In early periods, the condition of being hairless was mostly done as a way to keep the body clean, using flint, seashells, beeswax and various other depilatory utensils and exfoliator substances, some highly questionable and highly caustic. Ancient Rome also associated hair removal with status: a person with smooth skin was associated with purity and superiority. Removing body hair was done by both men and women. Psilothrum or psilotrum (Ancient Greek: ψίλωθρον) and dropax (Ancient Greek: δρῶπαξ) were depilatories in ancient Greece and Rome. An alipilus (Ancient Greek: παρατίλτριος) was a slave who attended bathers, removing unwanted body hair. The same practice applied to women, who were served by female slaves called παρατίλτριαι (the plural of παρατίλτρια, the feminine form of παρατίλτριος). In Ancient Egypt, besides being a fashion statement for affluent Egyptians of all genders, hair removal served as a treatment for louse infestation, which was a prevalent issue in the region. Very often, they would replace the removed head hair with a Nubian wig, which was seen as easier to maintain and also fashionable. Ancient Egyptian priests also shaved or depilated all over daily, so as to present a "pure" body before the images of the gods.
Sources: en.wikipedia.org
showed that small molecule inhibitors of Prp8 intein splicing were selective and effective at slowing the growth of C. neoformans and C. gattii, providing exciting evidence for the antimicrobial potential of intein splicing inhibitors.
==== Obsessive–compulsive disorder ==== Psilocybin has been studied for the treatment of obsessive–compulsive disorder. It is formally under development for treatment of OCD by multiple pharmaceutical companies. These include candidates with the developmental code names SYNP-101 (Ceruvia Lifesciences) and MLS-101 (MycoMedica Life Sciences).
==== Class B sub-family ==== Class B enzymes are the largest and most versatile which can methylate a wide range of carbon and phosphorus centers. These enzymes require a cobalamin (vitamin B12) cofactor as an intermediate methyl group carrier to transfer a methyl group from SAM to substrate. One well-investigated representative enzyme is TsrM which involves in tryptophan methylation in thiostrepton biosynthesis.
Bronchiolitis obliterans is often diagnosed based on the symptoms of obstructive lung disease following lung injury. The definitive diagnosis is through biopsy, but due to the variable distribution of lesions, leading to falsely negative tests, and invasive nature of this procedure it is often not performed. Several tests are often needed to diagnose bronchiolitis obliterans, including spirometry, diffusing capacity of the lung tests (DLCO), lung volume tests, chest X-rays, high-resolution CT (HRCT), and lung biopsy.
== Research and career == In 1975, Theo Wallimann completed his Ph.D. Dissertation on “M-line-bound Creatine Kinase and Myofibrillar Structure” in the laboratory of Prof. Hans M. Eppenberger at the Institute of Cell Biology at ETH Zurich with distinction and received the ETH prize and medal. From 1975 - 1981, Wallimann worked as a post-doctoral research associate with Andrew G. Szent-Györgyi , at the Biology Department of Brandeis University on the subject of "Myosin-linked calcium regulation of muscle contraction". After rejoining the Biology Dept of the ETH-Zurich in 1981, Wallimann became a Lecturer in 1984 with his Habilitation on: "Localization and function of M-line-bound creatine kinase: M-band model and Phospho-Creatine Shuttle"). In 1994, Wallimann was awarded the title of Professor and in the next two years he became Head and Deputy Head of the Institute of Cell Biology. Wallimann resigned from his post in June 2008 and is now Emeritus and member of the ETH Alumni organisation. In 2005, Wallimann was awarded with the Alfred-Vogt-Prize in 2005 and in 2023, 2024 and 2025 he received the Research.com Recognition Leader Award for Biology and Biochemistry in Switzerland. In 2025, Theo Wallimann has been honored by the International Society of Sports Nutrition with a “Life-time Achievement Award” for his research on the «Creatine Kinase System and Creatine», at the Internatl. Congress on «Creatine for Health», held during March 12th-16th 2025 in Munich, Germany: https://creatineforhealth.com/creatine-conference-2025/
Sources: en.wikipedia.org
==== Extracellular phenoloxidases ==== Phenols are an important group of ecotoxins due to their toxicity and persistence. Many microorganisms can degrade aromatic pollutants and use them as a source of energy, and the ability of microalgae to degrade a multitude of aromatic compounds including phenolic compounds is increasingly recognized. Some microalgae including Chlamydomonas sp., Chlorella sp., Scenedesmus sp. and Anabaena sp. are able to degrade various phenols such as pentachlorophenol, p-nitrophenol, and naphthalenesulfonic acids. Though the metabolic degradation pathways are not fully understood, enzymes including phenoloxidase laccase (EC 1.10.3.2) and laccase-like enzymes are involved in the oxidation of aromatic substrates. These exoenzymes can be potentially applied in the environmental degradation of phenolic pollutants.
The IDF said that one in five rockets launched by Hezbollah had landed in Lebanese territory and published an infographic showing failed rocket launches into Israel. On 16 December, a soldier from the IDF's 129th Battalion was killed by a Hezbollah drone strike near Margaliot, which also caused a fire in a building. Two other soldiers were injured. Another drone was shot down by the IDF, which also responded to the infiltrations by shelling targets. The IAF later hit several Hezbollah targets inside Lebanon, including rocket launch sites and military infrastructure. On 22 December, two IDF soldiers of the 188th Armored Brigade were killed by a Hezbollah rocket attack in the Shtula area. On the morning of 23 December, IDF aircraft bombed a house in Kfar Kila and intense artillery fire also took place on the outskirts of Deir Mimas The IDF conducted a raid near a UNIFL center along the Khardali River. An Al-Manar cameraman was injured in the eye after an IDF attack on a road in the al-Khardali area where correspondents of MTV and the state-owned National News Agency were also passing. Hezbollah announced that two of their members were killed on that day. On 24 December, senior IRGC general Razi Mousavi was killed by an Israeli airstrike in Damascus. On 26 December, a Hezbollah anti-tank missile hit St. Mary's Greek Orthodox Church in Iqrit, northern Israel. A civilian suffered serious injuries, and when IDF responders arrived at the scene, another missile was fired, injuring nine soldiers.
From 1946 through 1993, thirteen countries used ocean disposal or ocean dumping as a method to dispose of nuclear/radioactive waste with an approximation of 200,000 tons sourcing mainly from the medical, research and nuclear industry. Ocean floor disposal of radioactive waste has been suggested by the finding that deep waters in the North Atlantic Ocean do not present an exchange with shallow waters for about 140 years based on oxygen content data recorded over a period of 25 years. They include burial beneath a stable abyssal plain, burial in a subduction zone that would slowly carry the waste downward into the Earth's mantle, and burial beneath a remote natural or human-made island. While these approaches all have merit and would facilitate an international solution to the problem of disposal of radioactive waste, they would require an amendment of the Law of the Sea. Nuclear submarines have been lost and these vessels reactors must also be counted in the amount of radioactive waste deposited at sea. Article 1 (Definitions), 7., of the 1996 Protocol to the Convention on the Prevention of Marine Pollution by Dumping of Wastes and Other Matter, (the London Dumping Convention) states:
==== Electrolyte recycling ==== Electrolyte recycling consists of two phases. The collection phase extracts the electrolyte from the spent Li-ion battery. This can be achieved through mechanical processes, distillation, freezing, solvent extraction, and supercritical fluid extraction. Due to the volatility, flammability, and sensitivity of the electrolyte, the collection process poses a greater difficulty than the collection process for other components of a Li-ion battery. The next phase consists of separation/electrolyte regeneration. Separation consists of isolating the individual components of the electrolyte. This approach is often used for the direct recovery of the Li salts from the organic solvents. In contrast, regeneration of the electrolyte aims to preserve the electrolyte composition by removing impurities which can be achieved through filtration methods. The recycling of the electrolytes, which consists 10–15 wt.% of the Li-ion battery, provides both economic and environmental benefits. These benefits include the recovery of the valuable Li-based salts and the prevention of hazardous compounds, such as volatile organic compounds (VOCs) and carcinogens, being released into the environment. Compared to electrode recycling, less focus is placed on recycling the electrolyte of Li-ion batteries due to lower economic benefits and greater process challenges.
=== Maturana, narco-fútbol and the return to the World Cup (1987–1989) === The transformation began in May 1987, when the federation appointed Francisco Maturana — a former Once Caldas and Atlético Nacional coach then in charge of the youth setup — to the senior side. Maturana discarded the reactive schemes of his predecessors for a possession-based approach built on short passing, zonal marking and a crowded midfield, and licensed René Higuita to operate far from his goal as a sweeper-keeper — a style Colombian supporters came to call toque-toque.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.